nQ Medical (Accelerator)

Company Description: nQ Medical is an artificial intelligence company that has developed a computational biomarker that has been proven in five years of clinical trials to substantially change the way disease is managed for a wide range of neuromotor and neurocognitive disorders (Alzheimer's, Parkinson's, Multiple Sclerosis, ALS, mTBI, et al. nQ focuses on analysis of user interaction with common electronic devices to capture functional decline related to neurodegenerative disorders. The fine control of typing and touch screen kinematics together with the frequent use of electronic devices allows for precise monitoring of small changes in neurodegeneration that frequently go unnoticed by clinicians. nQ allows for early detection of disease, 24/7, passive, at home, remote monitoring of disease progression and the measurement of impact of therapy at a fraction of the cost of current gold standards. There is no required task. Just use your device as your would normally use it. nQ received Breakthrough Designation from the FDA in 2019.